Table 2 Costs of healthcare resources used [38,39,40]
From: Real-life cost-effectiveness of benralizumab in patients with severe asthma
Healthcare resource used | Unit cost in € |
|---|---|
Emergency visit | 144.24 |
Emergency visit + observation | 392.03 |
Hospital stay/day | 495.59 |
Hospital stay pneumology/day | 386.65 |
Spirometry | 40.57 |
Spirometry + bronchodilation | 60.49 |
Ig E determination | 21.50 |
FeNO determination | 39.00 |
Prick test | 134.70 |
Haemogram | 5.30 |
Biochemistry | 83.50 |
Non-contrast CT | 55.38 |
Drug | Dose | Therapeutic regimen | Annual cost |
|---|---|---|---|
Omalizumab | 150 mg | Based on both IgE level and weight | 17,042.61 |
Mepolizumab | 100 mg | 100 mg/4 weeks | 10,661.43 |
Benralizumab | 30 mg | Dose 30 mg/4 weeks; 3 doses; then 30 mg/8 weeks | 13,762.64 |
Corticosteroids | |||
Oral | 5 mg | 5 mg/day; 7-day course | 11.86 |
30 mg | 30 mg/day; 7-day course | 23.73 | |
Inhaled | 200 µg | Pack size: 200 puffs | 36.96 |